Ginkgo Bioworks, Inc. (“Ginkgo”) has engaged Rutgers, The State University of New Jersey, acting through RUCDR Infinite Biologics (“Rutgers”) to allow us to provide access to The Rutgers Clinical Genomics Laboratory TaqPath SARS-CoV-2 Assay performed in the Rutgers Clinical Genomics Laboratory, a CLIA-certified high complexity laboratory (the “Rutgers Test”).
The version of the Rutgers Test offered by Concentric by Ginkgo is a saliva-based test.
The Rutgers Test being offered by Concentric by Ginkgo is a PCR (polymerase chain reaction)-based test that is designed to detect the virus that causes COVID-19 in respiratory specimens, for example nasal, oral swabs, or saliva.
A PCR (polymerase chain reaction) test checks for genetic material (viral RNA) produced by the virus. This is used to detect the presence of the virus that causes COVID-19.